Mylan Must Divest In EU For Upjohn Merger
European Commission Sets Out Requirements To Approve Deal
The European Commission has approved Mylan’s merger with Pfizer’s Upjohn unit, on condition that the generics firm make a series of divestments in markets where the two firms’ strong positions and lack of other challengers would raise competition concerns.
